Oncology clinical trial starts growth rate vs Novel active substance launches

Oncology clinical trial starts growth rate and Novel active substance launches worldwide, compared over time.

Change the pair

Compare different indicators

The series

Over time

Global, spaced by time . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.

Oncology clinical trial starts growth rate

Unit: % · 3 observations

Line chart
Oncology clinical trial starts growth rateOncology clinical trial starts growth rate. 3 observations from 2014–2024 to 2024–2025, ranging from -4% to 58%. Latest value -4% (2024–2025). % -20 0 20 40 60 2004 2008 2012 2016 2020 2024 58% -4%
Oncology clinical trial starts growth rateOncology clinical trial starts growth rate. 3 observations from 2014–2024 to 2024–2025, ranging from -4% to 58%. Latest value -4% (2024–2025). % -20 0 20 40 60 2004 2008 2012 2016 2020 2024 58% -4%
Oncology clinical trial starts growth rateOncology clinical trial starts growth rate. 3 observations from 2014–2024 to 2024–2025, ranging from -4% to 58%. Latest value -4% (2024–2025). % -20 0 20 40 60 2004 2008 2012 2016 2020 2024 58% -4%
View the underlying data
Oncology clinical trial starts growth rate
Period Type Value
2014–2024 Actual 58%
2019–2024 Actual 12%
2024–2025 Actual -4%
Source: IQVIA · CC BY 4.0 · Full series

Novel active substance launches

Unit: count · 2 observations

Line chart
Novel active substance launchesNovel active substance launches. 2 observations from 2004–2023 to 2025, ranging from 79 to 942. Latest value 79 (2025). 0 200 400 600 800 1,000 2004 2008 2012 2016 2020 2024 942 79
Novel active substance launchesNovel active substance launches. 2 observations from 2004–2023 to 2025, ranging from 79 to 942. Latest value 79 (2025). 0 300 600 900 1,200 2004 2008 2012 2016 2020 2024 942 79
Novel active substance launchesNovel active substance launches. 2 observations from 2004–2023 to 2025, ranging from 79 to 942. Latest value 79 (2025). 0 300 600 900 1,200 2004 2008 2012 2016 2020 2024 942 79
View the underlying data
Novel active substance launches
Period Type Value
2004–2023 Actual 942
2025 Actual 79
Source: IFPMA, IQVIA · CC BY 4.0 · Full series

Provenance

Where these numbers come from

Oncology clinical trial starts growth rate

Annual percentage change in the total number of oncology clinical trial starts.

3 observations in Global · source organisations: IQVIA

Novel active substance launches

Total number of novel active substances launched.

2 observations in Global · source organisations: IFPMA, IQVIA

Data published under CC BY 4.0. Series A as JSON · Series B as JSON

Keep exploring

Related